Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodiesParastoo B Dahi, Jonathan Barone, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2013
"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftmentParastoo B Dahi, Doris M Ponce, Sean Devlin, et al.
Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.
British Journal of Haematology|March 6, 2020
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapyBrandon S Imber, Michel Sadelain, Carl DeSelm, et al.
Ophthalmology. Retina|April 23, 2021
Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T LymphocytesMrinali P Gupta, Lisa R Koenig, Ekaterina Doubrovina, et al.
Transplantation and Cellular Therapy|October 3, 2023
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell TransplantationKarthik Nath, Kristen Peterson, Samantha Brown, et al.
Transplantation and Cellular Therapy|December 19, 2024
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation RecipientsGyuri Han, Anat Stern, Yeon Joo Lee, et al.
Blood|June 19, 2014
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationYing Taur, Robert R Jenq, Miguel-Angel Perales, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2014
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphomaParastoo B Dahi, Roni Tamari, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2017
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic MalignanciesAnn A Jakubowski, Erica Petrlik, Molly Maloy, et al.
Pageof 9